These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 27704468)

  • 61. Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma.
    Fierro MT; Novelli M; Quaglino P; Comessatti A; Fava P; Ortoncelli M; Ponti R; Bernengo MG
    Dermatology; 2008; 216(3):213-21. PubMed ID: 18182812
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication.
    Dummer R; Döbbeling U; Geertsen R; Willers J; Burg G; Pavlovic J
    Blood; 2001 Jan; 97(2):523-7. PubMed ID: 11154232
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Staging and management of cutaneous T-cell lymphoma.
    Scarisbrick JJ
    Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas.
    Ni X; Zhang C; Talpur R; Duvic M
    J Invest Dermatol; 2005 Apr; 124(4):741-50. PubMed ID: 15816832
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
    Wong HK
    G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome.
    Fierro MT; Comessatti A; Quaglino P; Ortoncelli M; Osella Abate S; Ponti R; Novelli M; Bernengo MG
    Dermatology; 2006; 213(4):284-92. PubMed ID: 17135733
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mycosis Fungoides and Sezary Syndrome.
    Foss FM; Girardi M
    Hematol Oncol Clin North Am; 2017 Apr; 31(2):297-315. PubMed ID: 28340880
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
    Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
    Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Management of the cutaneous peripheral T-cell lymphomas: when subtypes matter.
    Choi MY; Lechowicz MJ
    Cancer J; 2012; 18(5):439-44. PubMed ID: 23006949
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Delving into the Metabolism of Sézary Cells: A Brief Review.
    Cherfan C; Chebly A; Rezvani HR; Beylot-Barry M; Chevret E
    Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790264
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases.
    Klemke CD; Booken N; Weiss C; Nicolay JP; Goerdt S; Felcht M; Géraud C; Kempf W; Assaf C; Ortonne N; Battistella M; Bagot M; Knobler R; Quaglino P; Arheiliger B; Santucci M; Jansen P; Vermeer MH; Willemze R
    Br J Dermatol; 2015 Jul; 173(1):93-105. PubMed ID: 25864856
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Memorials and mandates for cutaneous lymphomas.
    Heald PW
    Arch Dermatol; 2003 Jul; 139(7):926-8. PubMed ID: 12873891
    [No Abstract]   [Full Text] [Related]  

  • 73. A modified staging classification for cutaneous T-cell lymphoma.
    Kashani-Sabet M; McMillan A; Zackheim HS
    J Am Acad Dermatol; 2001 Nov; 45(5):700-6. PubMed ID: 11606919
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chromosomally clonal T cells in the skin, blood, or lymph nodes of two Sezary syndrome patients express CD45RA, CD45RO, CDw150, and interleukin-4, but no interleukin-2 or interferon-gamma.
    Karenko L; Nevala H; Raatikainen M; Franssila K; Ranki A
    J Invest Dermatol; 2001 Jan; 116(1):188-93. PubMed ID: 11168816
    [TBL] [Abstract][Full Text] [Related]  

  • 75. NOTCH1 signaling as a therapeutic target in Sézary syndrome.
    van der Fits L; Qin Y; Out-Luiting JJ; Vermeer KG; Whittaker S; van Es JH; Tensen CP; Vermeer MH
    J Invest Dermatol; 2012 Dec; 132(12):2810-7. PubMed ID: 22718117
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice.
    Gao J; Ren S; Choonoo G; Chen G; Frleta D; Zhong J; Gupta N; Sharma P; Oyejide A; Atwal GS; Macdonald L; Murphy A; Kuhnert F
    Dis Model Mech; 2023 Oct; 16(10):. PubMed ID: 37718909
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice.
    Harro CM; Perez-Sanz J; Costich TL; Payne KK; Anadon CM; Chaurio RA; Biswas S; Mandal G; Rigolizzo KE; Sprenger KB; Mine JA; Showe LC; Yu X; Liu K; Rodriguez PC; Pinilla-Ibarz J; Sokol L; Conejo-Garcia JR
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33270606
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genetic alterations in Sezary syndrome.
    Iżykowska K; Przybylski GK
    Leuk Lymphoma; 2011 May; 52(5):745-53. PubMed ID: 21323514
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Updated cutaneous T-cell lymphoma TNMB staging criteria fail to identify patients with Sézary syndrome with low blood burden.
    Chrisman LP; Trimark PF; Pang Y; Pease DR; Martinez-Escala ME; Nguyen WQ; Fernandez R; Griffin TL; Ayanruoh L; Hooper MJ; Zhou XA; Fu L; Wolniak KL; Guitart J
    Blood; 2024 Aug; 144(8):914-917. PubMed ID: 38848513
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Thymopentin in Sézary syndrome.
    Bernengo MG; Appino A; Bertero M; Novelli M; Fierro MT; Doveil GC; Lisa F
    J Natl Cancer Inst; 1992 Sep; 84(17):1341-6. PubMed ID: 1386633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.